NeuroVive Admitted to Trading on NASDAQ OMX Stockholm – International Business Times (press release)
|
NeuroVive Admitted to Trading on NASDAQ OMX Stockholm
International Business Times (press release) NeuroVive, a leading mitochondrial medicine company, announces that its shares have been approved for listing on NASDAQ OMX Stockholm by the exchange's Listing Committee. The first day of trading on NASDAQ OMX Stockholm will be April 10th and … |
